About ALLOS

Relentless commitment to oncology

The facts

Allos Therapeutics, Inc. is a biopharmaceutical company with a commitment to the development and commercialization of innovative anti-cancer therapeutics.

• The focus: Oncology
• Began operations: 1994
• Headquarters: Westminster, Colorado
• Commercial Operations: Princeton, New Jersey
• Employees: 100+ focused on clinical development and commercial operations
• IPO: March 2000
• Exchange/Symbol: Nasdaq/ALTH

The fundamentals

Allos Therapeutics’ key corporate operating principles are:

• Focus on excellence and innovation in the development and execution of our clinical programs
• Proactively evaluate opportunities to grow our business through potential product acquisitions, partnerships, and other strategic initiatives
• Lead with ethics and integrity to ensure quality business decisions that create value for our patients, employees, and stakeholders

The future

Allos Therapeutics is committed to addressing a variety of cancers, especially in areas of high unmet need where there are few or no current treatment options.

For more information, visit www.allos.com.